The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
Open accessAbstract
Most human coronaviruses cause mild upper respiratory tract disease but may be associated with more severe pulmonary disease in immunocompromised individuals. However, SARS coronavirus caused severe lower respiratory disease with nearly 10% mortality and evidence of systemic spread. Recently, another coronavirus (human coronavirus-Erasmus Medical Center (hCoV-EMC)) was identified in patients with severe and sometimes lethal lower respiratory tract infection. Viral genome analysis revealed close relatedness to coronaviruses found in bats. Here we identify dipeptidyl peptidase 4 (DPP4; also known as CD26) as a functional receptor for hCoV-EMC. DPP4 specifically co-purified with the receptor-binding S1 domain of the hCoV-EMC spike protein from lysates of susceptible Huh-7 cells. Antibodies directed against DPP4 inhibited hCoV-EMC infection of primary human bronchial epithelial cells and Huh-7 cells. Expression of human and bat (Pipistrellus pipistrellus) DPP4 in non-susceptible COS-7 cells enabled infection by hCoV-EMC. The use of the evolutionarily conserved DPP4 protein from different species as a functional receptor provides clues about the host range potential of hCoV-EMC. In addition, it will contribute critically to our understanding of the pathogenesis and epidemiology of this emerging human coronavirus, and may facilitate the development of intervention strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Preclinical studies showed that GLP-1RAs reduce cytokine production, attenuate pulmonary inflammation and preserve lung function in rats and mice with experimental lung injury [8, 32].”
From GLP-1 receptor agonists and renal outcomes in patients with diabetes mellitus type 2 and diabetic kidney disease: state of the art (2022) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,677
Self-citationA crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury
Kuba, K., Imai, Y., Rao, S., Gao, H., Guo, F., Guan, B., Huan, Y., Yang, P., Zhang, Y., Deng, W., et al. (2005) · Nature Medicine · doi:10.1038/nm1267 · Cited by 3,445
Bats Are Natural Reservoirs of SARS-Like Coronaviruses
Li, W., Shi, Z., Yu, M., Ren, W., Smith, C. S., Epstein, J. H., Wang, H., Crameri, G. S., Hú, Z., Zhang, H., et al. (2005) · Science · doi:10.1126/science.1118391 · Cited by 2,571
Angiotensin-converting enzyme 2 protects from severe acute lung failure
Imai, Y., Kuba, K., Rao, S., Huan, Y., Guo, F., Guan, B., Yang, P., Sarao, R., Wada, T., Leong-Poi, H., et al. (2005) · Nature · doi:10.1038/nature03712 · Cited by 2,453
Structure of SARS Coronavirus Spike Receptor-Binding Domain Complexed with Receptor
Li, F., Li, W., Farzan, M., & Harrison, S. C. (2005) · Science · doi:10.1126/science.1116480 · Cited by 2,035
Coronavirus Pathogenesis and the Emerging Pathogen Severe Acute Respiratory Syndrome Coronavirus
Weiss, S. R., & Navas-Martin, S. (2005) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.69.4.635-664.2005 · Cited by 1,256
Severe acute respiratory syndrome
Peiris, M. J. S., Guan, Y., & Yuen, K. (2004) · Nature Medicine · doi:10.1038/nm1143 · Cited by 1,157
Lambeir, A.-M., Durinx, C., Scharpé, S., & De Meester, I. (2003) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/713609354 · Cited by 955
Human aminopeptidase N is a receptor for human coronavirus 229E
Yeager, C. L., Ashmun, R. A., Williams, R. K., Cardellichio, C. B., Shapiro, L. H., Look, A. T., & Holmes, K. V. (1992) · Nature · doi:10.1038/357420a0 · Cited by 941
Flagged first, then by citations
Cited by
Sorted by citations
Items 801–900 of 1,000
Alnuqaydan, A. M., Almutary, A. G., Sukamaran, A., Yang, B. T. W., Lee, X. T., Lim, W. X., Ng, Y. M., Ibrahim, R., Darmarajan, T., Satheeshkumar, N., et al. (2021) · AAPS PharmSciTech · doi:10.1208/s12249-021-02062-2 · Cited by 33
TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction
Khan, H., Winstone, H., Jiménez-Guardeño, J. M., Graham, C., Doores, K. J., Goujon, C., Matthews, D. A., Davidson, A. D., Rihn, S. J., Palmarini, M., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009820 · Cited by 34
Meunier, T., Desmarets, L. M. B., Bordage, S., Bamba, M., Hervouet, K., Rouillé, Y., François, N., Décossas, M., Sencio, V., Trottein, F., et al. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01581-21 · Cited by 33
Sharif-zak, M., Abbasi-Jorjandi, M., Asadikaram, G., Ghoreshi, Z., Rezazadeh-Jabalbarzi, M., afsharipur, A., Rashidinejad, H., Khajepour, F., Jafarzadeh, A., Arefinia, N., et al. (2022) · Immunobiology · doi:10.1016/j.imbio.2022.152184 · Cited by 33
Conserved recombination patterns across coronavirus subgenera
de Klerk, A., Swanepoel, P., Lourens, R., Zondo, M., Abodunran, I., Lytras, S., MacLean, O. A., Robertson, D. L., Pond, S. L. K., Zehr, J. D., et al. (2022) · Virus Evolution · doi:10.1093/ve/veac054 · Cited by 33
Engineered disulfide reveals structural dynamics of locked SARS-CoV-2 spike
Qu, K., Chen, Q., Ciazynska, K. A., Liu, B., Zhang, X., Wang, J., He, Y., Guan, J., He, J., Liu, T., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010583 · Cited by 33
Factors determining human-to-human transmissibility of zoonotic pathogens via contact
Richard, M., Knauf, S., Lawrence, P., Mather, A. E., Munster, V. J., Müller, M. A., Smith, D. J., & Kuiken, T. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.11.004 · Cited by 35
Self-citationNeurologic complications of coronavirus and other respiratory viral infections
Cavallieri, F., Sellner, J., Zedde, M., & Moro, E. (2022) · Handbook of clinical neurology · doi:10.1016/b978-0-323-91532-8.00004-5 · Cited by 32
The potential effects of DPP‐4 inhibitors on cardiovascular system in COVID‐19 patients
Du, H., Wang, D. W., & Chen, C. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15674 · Cited by 32
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a newly emerged pathogen: an overview
Rathore, J. S., & Ghosh, C. (2020) · Pathogens and Disease · doi:10.1093/femspd/ftaa042 · Cited by 32
DPP4 Inhibitors and COVID-19–Holy Grail or Another Dead End?
Krejner‐Bienias, A., Grzela, K., & Grzela, T. (2021) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-020-00602-5 · Cited by 32
Sharifi, Y., Payab, M., Mohammadi‐Vajari, E., Aghili, S. M. M., Sharifi, F., Mehrdad, N., Kashani, E., Shadman, Z., Larijani, B. A., & Ebrahimpur, M. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00822-2 · Cited by 32
The Spike of SARS-CoV-2: Uniqueness and Applications
Kumavath, R., Barh, D., Andrade, B. S., Imchen, M., Aburjaile, F. F., Ch, A., Rodrigues, D. L. N., Tiwari, S., Alzahrani, K. J., Goés‐Neto, A., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.663912 · Cited by 34
Cellular and Molecular Effects of SARS-CoV-2 Linking Lung Infection to the Brain
Francistiová, L., Klepe, A., Curley, G., Gulya, K., Dinnyés, A., & Filkor, K. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.730088 · Cited by 36
ACE2 function in the pancreatic islet: Implications for relationship between SARS‐CoV‐2 and diabetes
Memon, B., & Abdelalim, E. M. (2021) · Acta Physiologica · doi:10.1111/apha.13733 · Cited by 34
Advances in mRNA and other vaccines against MERS-CoV
Tai, W., Zhang, X., Yang, Y., Zhu, J., & Du, L. (2021) · Translational research · doi:10.1016/j.trsl.2021.11.007 · Cited by 36
Broad reception for coronavirus
Gallagher, T., & Perlman, S. M. (2013) · Nature · doi:10.1038/495176a · Cited by 32
What are our pharmacotherapeutic options for MERS-CoV?
Al‐Tawfiq, J. A., & Memish, Z. A. (2014) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2014.890515 · Cited by 32
Warren, R. L., & Birol, İ. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa756 · Cited by 31
Otter, C. J., Renner, D. M., Fausto, A., Tan, L., Cohen, N. A., & Weiss, S. R. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2402540121 · Cited by 31
Kim, J., Yang, Y., Jeong, Y., & Jang, Y. (2020) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1910.10055 · Cited by 31
Bouhanick, B., Cracowski, J., & Faillie, J.-L. (2020) · Therapies · doi:10.1016/j.therap.2020.05.006 · Cited by 31
Nucleic Acid-Sensing Pathways During SARS-CoV-2 Infection: Expectations versus Reality
Mdkhana, B., Sharif‐Askari, N. S., Ramakrishnan, R. K., Goel, S., Hamid, Q. A., & Halwani, R. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s277716 · Cited by 31
COVID-19 infection and body weight: A deleterious liaison in a J-curve relationship
Manolis, A. S., Manolis, T. A., Manolis, T. A., Apostolaki, N. E., & Melita, H. (2021) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2021.10.006 · Cited by 31
The Effects of Extrinsic and Intrinsic Factors on Neurogenesis
Jiang, M. H., Jang, S. E., & Zeng, L. (2023) · Cells · doi:10.3390/cells12091285 · Cited by 34
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
Bhatta, A., Sahoo, S., Teja, K. B., & Tomar, S. J. (2023) · Springer eBooks · doi:10.1007/978-981-99-2820-0_6 · Cited by 31
A MERS-CoV antibody neutralizes a pre-emerging group 2c bat coronavirus
Tse, L. V., Hou, Y. J., McFadden, E., Lee, R. E., Scobey, T., Leist, S. R., Martinez, D. R., Meganck, R. M., Schäfer, A., Yount, B. L., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adg5567 · Cited by 31
Wang, C., & Quan, Z. (2021) · Chinese Journal of Electronics · doi:10.1049/cje.2021.06.003 · Cited by 30
Respiratory viruses interacting with cells: the importance of electrostatics
Lauster, D. C., Osterrieder, N., Haag, R., Ballauff, M., & Herrmann, A. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1169547 · Cited by 34
Sung, H., Yong, D., Ki, C., Kim, J., Seong, M., Lee, H., & Kim, M. (2016) · Annals of Laboratory Medicine · doi:10.3343/alm.2016.36.5.457 · Cited by 30
Rodon, J., Okba, N. M. A., Te, N., van Dieren, B., Bosch, B., Bensaïd, A., Segalés, J., Haagmans, B. L., & Vergara‐Alert, J. (2019) · Emerging Microbes & Infections · doi:10.1080/22221751.2019.1685912 · Cited by 30
Self-citationIs DPP4 inhibition a comrade or adversary in COVID-19 infection
Dalan, R. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108216 · Cited by 30
Heat Shock Protein Member 8 Is an Attachment Factor for Infectious Bronchitis Virus
Zhu, P., Lv, C., Fang, C., Peng, X., Sheng, H., Xiao, P., Ojha, N. K., Yan, Y., Liao, M., & Zhou, J. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01630 · Cited by 30
Konwar, M., & Sarma, D. (2020) · Tetrahedron · doi:10.1016/j.tet.2020.131761 · Cited by 30
Zhou, J., Wu, B., Wang, W., Lei, F., Cheng, X., Qin, J., Cai, J., Zhang, X., Zhou, F., Liu, Y.-M., et al. (2020) · World Journal of Clinical Cases · doi:10.12998/wjcc.v8.i22.5576 · Cited by 30
González, F., Correa, C. I. C., & Peñaranda, E. (2020) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2020.11.013 · Cited by 30
Heparan sulfates from bat and human lung and their binding to the spike protein of SARS-CoV-2 virus
Yan, L., Song, Y., Xia, K., He, P., Zhang, F., Chen, S., Pouliot, R. A., Weiss, D. J., Tandon, R., Bates, J. T., et al. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.117797 · Cited by 30
New perspectives on natural flavonoids on COVID ‐19‐induced lung injuries
Santana, F. P. R., Thevenard, F., Gomes, K. S., Taguchi, L., Câmara, N. O. S., Stilhano, R. S., Ureshino, R. P., Prado, C. M., & Lago, J. H. G. (2021) · Phytotherapy Research · doi:10.1002/ptr.7131 · Cited by 30
Inhibitory effect on SARS‐CoV‐2 infection of neferine by blocking Ca2+‐dependent membrane fusion
Yang, Y., Yang, P., Huang, C., Wu, Y., Zhou, Z., Wang, X., & Wang, S. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27117 · Cited by 30
Mouse Models for the Study of SARS-CoV-2 Infection
Knight, A. C., Montgomery, S. A., Fletcher, C., & Baxter, V. K. (2021) · Comparative Medicine · doi:10.30802/aalas-cm-21-000031 · Cited by 31
A perspective on the applications of furin inhibitors for the treatment of SARS-CoV-2
Devi, K. P., Pourkarim, M. R., Thijssen, M., Sureda, A., Khayatkashani, M., Cismaru, C. A., Neagoe, I. B., Habtemariam, S., Razmjouei, S., & Kashani, H. R. K. (2022) · Pharmacological Reports · doi:10.1007/s43440-021-00344-x · Cited by 30
Strategies for fighting pandemic virus infections: Integration of virology and drug delivery
Nakamura, T., Isoda, N., Sakoda, Y., & Harashima, H. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.046 · Cited by 32
Spiking the MERS-coronavirus receptor
Bosch, B., Raj, V. S., & Haagmans, B. L. (2013) · Cell Research · doi:10.1038/cr.2013.108 · Cited by 30
Self-citationMillet, J. K., Goldstein, M. E., Labitt, R. N., Hsu, H.-L., Daniel, S., & Whittaker, G. R. (2016) · Emerging Microbes & Infections · doi:10.1038/emi.2016.125 · Cited by 30
DPP4-directed therapeutic strategies for MERS-CoV
Reinhold, D., & Brocke, S. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70696-0 · Cited by 30
Eifan, S. A., Nour, I., Hanif, A., Zamzam, A., & AlJohani, S. M. (2017) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2017.06.001 · Cited by 29
Middle East respiratory syndrome coronavirus: five years later
Rabaan, A. A. (2017) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2017.1367288 · Cited by 29
Woo, P. C. Y., Lau, S. K. P., Chen, Y., Wong, E. Y. M., Chan, K., Chen, H., Zhang, L., Xia, N., & Yuen, K. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-017-0016-7 · Cited by 29
Ys, K., Aigerim, A., Park, U., Kim, Y., Rhee, J.-Y., Choi, J., Park, W. B., Park, S., Kim, Y., Lim, D., et al. (2019) · Emerging infectious diseases · doi:10.3201/eid2506.181722 · Cited by 29
Guo, X., Mu, S., Li, J., Zhang, Y., Liu, X., Zhang, H., & Gao, H. J. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb02301a · Cited by 29
Tsai, P., Wang, M., Yang, D., Liang, K.-H., Chou, S., Chiou, S., Lin, T.-H., Wang, C.-T., & Chang, T.-J. (2020) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000387 · Cited by 29
Kleen, T. O., Galdon, A. A., MacDonald, A. S., & Dalgleish, A. G. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02059 · Cited by 29
Obesity and COVID ‐19: A jigsaw puzzle with still missing pieces
Michalakis, K. G., Panagiotou, G., Ilias, Ι., & Pazaitou‐Panayiotou, K. (2020) · Clinical Obesity · doi:10.1111/cob.12420 · Cited by 29
Kallikrein 13 serves as a priming protease during infection by the human coronavirus HKU1
Milewska, A., Falkowski, K., Kulczycka, M., Bielecka, E., Naskalska, A., Mak, P., Lesner, A., Ochman, M., Urlik, M., Diamandis, E. P., et al. (2020) · Science Signaling · doi:10.1126/scisignal.aba9902 · Cited by 30
Basic mechanisms of SARS-CoV-2 infection. What endocrine systems could be implicated?
Soldevila, B., Puig‐Domingo, M., & Marazuela, M. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-021-09678-6 · Cited by 29
Pleiotropic Benefits of DPP-4 Inhibitors Beyond Glycemic Control
Kang, S. M., & Park, J. H. (2021) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/11795514211051698 · Cited by 31
Xie, L., Zhang, Z., Wang, Q., Chen, Y., Lu, D., & Wu, W. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.772865 · Cited by 30
Diversity of Coronaviruses with Particular Attention to the Interspecies Transmission of SARS-CoV-2
Shehata, A. A., Attia, Y. A., Rahman, M. T., Basiouni, S., El-Seedi, H. R., Azhar, E. I., Khafaga, A. F., & Hafez, H. M. (2022) · Animals · doi:10.3390/ani12030378 · Cited by 30
Fantini, J., Azzaz, F., Chahinian, H., & Yahi, N. (2023) · Viruses · doi:10.3390/v15020284 · Cited by 30
DYRK1A promotes viral entry of highly pathogenic human coronaviruses in a kinase-independent manner
Strine, M. S., Cai, W. L., Wei, J., Alfajaro, M. M., Filler, R. B., Biering, S. B., Sarnik, S. A., Chow, R. D.-W., Patil, A., Cervantes, K. S., et al. (2023) · PLoS Biology · doi:10.1371/journal.pbio.3002097 · Cited by 29
Eckerle, I., Lenk, M., & Ulrich, R. G. (2014) · Viruses · doi:10.3390/v6030951 · Cited by 29
Lipidation increases antiviral activities of coronavirus fusion-inhibiting peptides
Park, J.-E., & Gallagher, T. (2017) · Virology · doi:10.1016/j.virol.2017.07.033 · Cited by 29
Batool, M., Shah, M., Patra, M. C., Yesudhas, D., & Choi, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-11736-6 · Cited by 29
Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice
Cohen, A. A., Gnanapragasam, P. N. P., Lee, Y. E., Hoffman, P. R., Ou, S. K.-H., Kakutani, L. M., Keeffe, J. R., Wu, H., Howarth, M. R., West, A. P., et al. (2021) · CaltechAUTHORS (California Institute of Technology) · Cited by 29
Human cell receptors: potential drug targets to combat COVID-19
Raghav, P. K., Kalyanaraman, K., & Kumar, D. (2021) · Amino Acids · doi:10.1007/s00726-021-02991-z · Cited by 29
Person-to-Person Spread of the MERS Coronavirus — An Evolving Picture
Perlman, S. M., & McCray, P. B. (2013) · New England Journal of Medicine · doi:10.1056/nejme1308724 · Cited by 29
Ma, D.-K., Wu, W.-C., Ling, X., Kang, E.-C., Lin, J.-Y., Chen, H., & Lai, C. (2020) · Taiwan Journal of Ophthalmology · doi:10.4103/tjo.tjo_53_20 · Cited by 28
Bat organoids reveal antiviral responses at epithelial surfaces
Kellner, M. J., Monteil, V., Zelger, P., Pei, G., Jiao, J., Onji, M., Nayak, K., Zilbauer, M., Balkema‐Buschmann, A., Dorhoi, A., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02155-1 · Cited by 29
A Comparative Review of Animal Models of Middle East Respiratory Syndrome Coronavirus Infection
Baseler, L. J., de Wit, E., & Feldmann, H. (2016) · Veterinary Pathology · doi:10.1177/0300985815620845 · Cited by 28
Algaissi, A. A., Agrawal, A. S., Han, S., Peng, B., Luo, C., Li, F., Chan, T., Couch, R. B., & Tseng, C.-T. K. (2018) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiy574 · Cited by 28
Chen, Y.-C., Chen, T., Sun, C.-C., Chen, J., Chang, S.-S., Yeung, L., & Tsai, Y. (2020) · Acta Diabetologica · doi:10.1007/s00592-020-01533-5 · Cited by 28
Evaluation of Coronavirus Families & Covid-19 Proteins: Molecular Modeling Study
(2020) · Biointerface Research in Applied Chemistry · doi:10.33263/briac105.60396057 · Cited by 28
Can SARS-CoV-2 infect the eye? An overview of the receptor status in ocular tissue
Schnichels, S., Rohrbach, J. M., Bayyoud, T., Thaler, S., Ziemssen, F., & Hurst, J. (2020) · Der Ophthalmologe · doi:10.1007/s00347-020-01281-5 · Cited by 28
Emerging Human Coronavirus Infections (SARS, MERS, and COVID-19): Where They Are Leading Us
Kumar, V. (2020) · International Reviews of Immunology · doi:10.1080/08830185.2020.1800688 · Cited by 29
Renin Angiotensin System, COVID-19 and Male Fertility: Any Risk for Conceiving?
Pascolo, L., Zito, G., Zupin, L., Luppi, S., Giolo, E., Martinelli, M., Rocco, D. D., Crovella, S., & Ricci, G. (2020) · Microorganisms · doi:10.3390/microorganisms8101492 · Cited by 28
Mohamed, D. Z., Ghoneim, M. E.-S., Abu-Risha, S. E.-S., Abdelsalam, R. A., & Farag, M. A. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i28.4504 · Cited by 31
Liu, T., Feng, M., Wen, Z., He, Y., Lin, W., & Zhang, M. (2021) · Journal of Inflammation Research · doi:10.2147/jir.s329697 · Cited by 29
Known Cellular and Receptor Interactions of Animal and Human Coronaviruses: A Review
Everest, H., Stevenson-Leggett, P., Bailey, D., Bickerton, E., & Keep, S. (2022) · Viruses · doi:10.3390/v14020351 · Cited by 28
Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines
Guan, X., Yang, Y., & Du, L. (2023) · Expert Review of Vaccines · doi:10.1080/14760584.2023.2211153 · Cited by 29
Virus discovery: one step beyond
Smits, S. L., & Osterhaus, A. D. M. E. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.03.007 · Cited by 29
Self-citationFukuma, A., Tani, H., Taniguchi, S., Shimojima, M., Saijo, M., & Fukushi, S. (2015) · Archives of Virology · doi:10.1007/s00705-015-2506-z · Cited by 28
Advancing Priority Research on the Middle East Respiratory Syndrome Coronavirus
Hui, D. S. C., & Zumla, A. I. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit591 · Cited by 27
Research progress and challenges to coronavirus vaccine development
Zhou, P., Li, Z., Xie, L., An, D., Fan, Y., Wang, X., Li, Y., Liu, X., Wu, J., Li, G., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26517 · Cited by 27
Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector system
de Queiroz, N. M. G. P., Marinho, F. V., Chagas, M., Leite, L. C. C., Homan, E. J., de Magalhães, M. T. Q., & Oliveira, S. C. (2020) · Microbes and Infection · doi:10.1016/j.micinf.2020.09.004 · Cited by 27
Why are ACE2 binding coronavirus strains SARS‐CoV / SARS‐CoV ‐2 wild and NL63 mild?
Rawat, P., Jemimah, S., Ponnuswamy, P. K., & Gromiha, M. M. (2020) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26024 · Cited by 27
Vallianou, N. G., Evangelopoulos, A. A., Kounatidis, D. C., Stratigou, T., Christodoulatos, G. S., Karampela, Ι., & Dalamaga, Μ. (2021) · Current Diabetes Reviews · doi:10.2174/1573399817666210101110253 · Cited by 27
Acute Kidney Injury and Covid-19: A Scoping Review and Meta-Analysis
Jafari‐Oori, M., Fiorentino, M., Castellano, G., Ebadi, A., Rahimi‐Bashar, F., Guest, P. C., Vahedian‐Azimi, A., & Sahebkar, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-59261-5_28 · Cited by 27
Evolution, Ecology, and Zoonotic Transmission of Betacoronaviruses: A Review
Jelinek, H. F., Mousa, M., Alefishat, E. A., Osman, W. M., Spence, I., Bu, D., Feng, S. F., Byrd, J. H., Magni, P. A., Sahibzada, S., et al. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.644414 · Cited by 28
Plant derived active compounds as potential anti SARS-CoV-2 agents: an in-silico study
Kashyap, D., Jakhmola, S., Tiwari, D., Kumar, R., Moorthy, N. S. H. N., Manivannan, E., Brás, N. F., & Jha, H. C. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1947384 · Cited by 27
Rapid generation of mouse model for emerging infectious disease with the case of severe COVID-19
Sun, C., Jan, J., Wang, I.-H., Ma, H., Ko, H., Wu, P., Kuo, T.-J., Liao, H.-N., Lan, Y.-H., Sie, Z., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009758 · Cited by 28
Host Kinase CSNK2 is a Target for Inhibition of Pathogenic SARS-like β-Coronaviruses
Yang, X., Dickmander, R. J., Bayati, A., Taft-Benz, S., Smith, J. L., Wells, C. I., Madden, E. A., Brown, J. W., Lenarcic, E. M., Yount, B. L., et al. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.2c00378 · Cited by 29
Therapeutic nanobodies against SARS-CoV-2 and other pathogenic human coronaviruses
Yang, Y., Li, F., & Du, L. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02573-7 · Cited by 27
Kim, Y., Lee, H., Park, K., Park, S., Lim, J., So, M. K., Woo, H., Ko, H., Lee, J. M., Lim, S. H., et al. (2019) · Antibodies · doi:10.3390/antib8030042 · Cited by 27
Ababneh, M. M. K., Alrwashdeh, M., & Khalifeh, M. (2019) · Veterinary World · doi:10.14202/vetworld.2019.1554-1562 · Cited by 26
Pillaiyar, T. (2015) · Medicinal Chemistry · doi:10.4172/2161-0444.1000287 · Cited by 26
Hashemzadeh, A., Avan, A., Ferns, G. A., & Khazaei, M. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.07.003 · Cited by 26
Stout, A. E., Millet, J. K., Stanhope, M. J., & Whittaker, G. R. (2021) · One Health · doi:10.1016/j.onehlt.2021.100282 · Cited by 27
Ortega-Rivera, O. A., Shukla, S., Shin, M. D., Chen, A., Beiss, V., Moreno‐Gonzalez, M. A., Zheng, Y., Clark, A. E., Carlin, A. F., Pokorski, J. K., et al. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.1c00410 · Cited by 26
Monto, A. S., Cowling, B. J., & Peiris, M. J. S. (2014) · Springer eBooks · doi:10.1007/978-1-4899-7448-8_10 · Cited by 27
A Case Report of a Middle East Respiratory Syndrome Survivor with Kidney Biopsy Results
Cha, R., Yang, S. H., Moon, K. C., Joh, J.-S., Lee, J. Y., Shin, H., Kim, D. K., & Kim, Y. S. (2016) · Journal of Korean Medical Science · doi:10.3346/jkms.2016.31.4.635 · Cited by 26
Metadata
- Authors
- Raj, V. S., Mou, H., Smits, S. L., Dekkers, D. H. W., Müller, M. A., Dijkman, R., Muth, D., Demmers, J. A. A., Zaki, A., Fouchier, R. A. M., Thiel, V., Drosten, C., Rottier, P. J. M., Osterhaus, A. D. M. E., Bosch, B. J., & Haagmans, B. L.
- Affiliations
- Erasmus MC (NL)
- Utrecht University (NL)
- University of Bonn (DE)
- Kantonsspital St. Gallen (CH)
- Soliman Fakeeh Hospital (SA)
- University of Zurich (CH)
- Corresponding author
- Bosch, Berend Jan
- Haagmans, Bart L.
- ORCID
- Venue
- Nature
- Published
- 2013-03
- Volume
- 495
- Issue
- 7440
- Pages
- 251-254
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC7095326
- OpenAlex
- W2119111857
- Cited by
- 2,061
- References
- 25
- Citations by year
- 2026: 41 · 2025: 64 · 2024: 97 · 2023: 130 · 2022: 199 · 2021: 358 · 2020: 609 · 2019: 74 · 2018: 59 · 2017: 61 · 2016: 93 · 2015: 101 · 2014: 86 · 2013: 87
- FWCI
- 89.49
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- Funders
- National Science Foundation
- European Commission (223498, 278976)
- Deutsche Forschungsgemeinschaft (DR 772/3-1, KA1241/18-1, 772/3)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (132898)
- Bundesministerium für Bildung und Forschung
- China Scholarship Council
- Stiftung Forschung 3R (128-11)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- MERS-CoV, dipeptidyl peptidase IV, CD26, viral receptor, host range, lower respiratory tract infection, SARS-CoV, receptor binding domain, Huh7 cells, bronchial epithelial cells
- MeSH terms
- Animals, Chlorocebus aethiops, Chiroptera, Epithelial Cells, Humans, Molecular Sequence Data, Receptors, Virus, Coronavirus, Coronavirus Infections, Dipeptidyl Peptidase 4, COS Cells, Bronchioles, Host Specificity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review